Ticker Hub

ADMT

ADM TRONICS UNLTD INC

Latest price

$0.0729+12.15%

As of Nov 4, 2026, 3:52 PM EST · Market data by Massive

Market cap

—

Volume

182.7K

Previous close

$0.0650

Day range

$0.0650 – $0.0763

Listed

—

Coverage

4 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$0.0954$0.0838$0.0721$0.0605$0.0489Fri, 10/30Mon, 11/2Tue, 11/3Wed, 11/4Thu, 11/5
Five-day open $0.0489Latest interval $0.0954

Newsroom

Latest ADMT coverage

ADM Tronics Releases Pre-Production Evaluation Units of New Vet-Sonotron Therapy Device for Veterinary Market
NewsNov 1, 2021

ADM Tronics Releases Pre-Production Evaluation Units of New Vet-Sonotron Therapy Device for Veterinary Market

[ad_1] Northvale, NJ – (NewMediaWire) – November 1, 2021 – ADM Tronics Unlimited, Inc. (OTCQB – ADMT) has completed development of its new Vet-Sonotron® device and has released pre-production evaluation units for the animal therapy markets.   The Vet-Sonotron is a veterinary electronic therapy device for the treatment of musculoskelet

ADMNJOTCQBADMT
ADM Tronics Receives First Place in the Category of Electronics at the 2021 Go Global Awards
NewsOct 18, 2021

ADM Tronics Receives First Place in the Category of Electronics at the 2021 Go Global Awards

[ad_1] Northvale, NJ – (NewMediaWire) – October 18, 2021 – ADM
 Tronics Unlimited, Inc. (OTCQB – ADMT) was announced as First Place winner in
 the category of Electronics at the International Trade Council's Annual Go
 Global Awards Ceremony October 14, 2021. This year’s awards were
 presented by the Go Global Judging

ADMNJOTCQBADMT
ADM Tronics to Participate at Lytham Partners Summer 2021 Investor Conference
NewsJun 7, 2021

ADM Tronics to Participate at Lytham Partners Summer 2021 Investor Conference

[ad_1] Northvale, NJ – (NewMediaWire) – June 7, 2021 – ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced today that it will be participating at the Lytham Partners Summer 2021 Investor Conference.   Andre DiMino, President of ADMT, will be available for virtual one-on-one meetings throughout the event, which runs from June 14, 2021 throug

ADMT
Novel Therapeutic Technology Developed and Manufactured by ADM Tronics for Origin, Inc., Submitted to FDA for Investigational Exemption to Conduct Studies on COVID Patients
NewsOct 7, 2020

Novel Therapeutic Technology Developed and Manufactured by ADM Tronics for Origin, Inc., Submitted to FDA for Investigational Exemption to Conduct Studies on COVID Patients

[ad_1] Northvale, NJ – (NewMediaWire) – October 6, 2020 – ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has been advised that Origin, Inc. filed an Investigational Device Exemption (“IDE”) application with the FDA to conduct clinical studies to treat patients diagnosed with COVID-19 with its plasma-generated nitric oxide (“NO”) technology.  ADM

ADMT
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.